Connect with us

Health

Lagos govt says negotiations are ongoing with manufacturers to make COVID-19 vaccines available

Published

on

Estimated Reading Time: 1

Lagos State Government is currently in discussion with manufacturers of COVID-19 viral vector vaccine with a view to making vaccine available to residents amid spike in cases of patients infected with the virus.

The state Attorney General and Commissioner for Justice, Moyosore Onigbanjo, SAN, disclosed this on Saturday while reacting to a statement addressed to him by a concerned citizen, simply identified as Mr. Uthman, accusing the state government of incapacity and unwillingness to enforce compliance with COVID-19 pandemic protocols in the state.

NewsWireNGR recalls that the Minister of Health, Dr. Osagie Ehanire, had said the country was expecting over 10 million doses of the COVID-19 viral vector vaccine which is expected to arrive sometime in March 2021.

Speaking on the availability of vaccine in the state, Onibanjo said the measure became necessary following rising cases of patients needing treatments urgently.

According to him, “It is correct that Lagos State has the highest number of infections and sadly fatalities from COVID-19 in Nigeria. The State Government itself never shied away from admitting that Lagos is indeed the epicenter of the virus in Nigeria. But is it “business-as-usual”? Most certainly not.

“Since the first index patient was confirmed on 27 February 2020, Lagos State Government has led from the front in tackling the pandemic. It was Lagos State who also first introduced; reduced working hours for all sectors of the economy in the State; directed that all its staff between levels 1-14 should work from home; closed all bars, gyms, lounges and cinemas; restricted restaurants to offering take-out services only; and closed worship centres.

“The first lockdown, to contain the pandemic was declared in Lagos on 30 March 2020.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *